During the past decade, performance of minimally invasive surgery (MIS) has rapidly disseminated into clinical practice for commonly performed procedures in the United States owing to lowering of the risk for complications, shortening of the length of stay, and improving convalescence compared with open surgery.1,2 Assessing the effect of MIS on the risk for surgical site infections (SSIs) is a salient question, because SSIs occur in at least 2% of all surgical procedures and are increasingly targeted under contemporary health care reform.3